Mergers & Acquisitions
-
Opportunity India Desk Sep 29, 2017 - 2 min readOne of the largest and fastest home healthcare provider, Portea Medical have entered into a strategic alliance with American Megatrends Inc., (AMI) with a leader in the development of smart diagnostic devices, with an aim to deliver improved health outcomes for homecare patients. We are pleased to enter this partnership with AMI that emphasizes ...
-
Opportunity India Desk Sep 29, 2017 - 3 min readRoyal Philips, a leader in image-guided therapies and Ion Beam Applications (IBA), the globally renowned provider of protontherapy solutions to treat cancer, has announced the signingof an exclusive agreement to enhance access to proton therapy in India. Proton therapy is appropriate for the treatment of eye and brain cancers, tumors close to the brain ...
-
Opportunity India Desk Sep 29, 2017 - 2 min readWith an aim to establish its presence in western UP, Gurgaon’s leading super specialty Paras Hospitals has joined hands with Anand Hospital, Meerut, to provide advanced support in performing high quality joint replacement procedures in the city. The initiative will help patients in Meerut receive medical support from some of India’s leading orthopedic and ...
-
Opportunity India Desk Sep 29, 2017 - 2 min readAs FMCG major Emami Ltd has acquired hair and scalp-care business under the Kesh King and allied brands by entering into an agreement with Sanjeev Juneja, the next announcement made by the former is to take EPS accretive route from late 2017. As per the recent report released by leading business channel CNBC TV18, ...
-
Opportunity India Desk Sep 29, 2017 - 2 min readAfter gaining limelight for its holistic wellness approach, Ananda in Himalayas has forayed into fitness industry by collaborating with Delhi-based SUMAYA, to recast its wellness offerings with an enhanced focus on fitness. Brainchild of renowned fitness expert Sumaya Dalmia, SUMAYA’s core focus is personal training that fits well with Ananda’s philosophy of personalized holistic wellness. ...
-
Opportunity India Desk Sep 29, 2017 - 2 min readIn a fresh business move, Max Healthcare has announced to acquire a controlling stake of 76 per cent in Delhi-based Pushpanjali Crosslay Hospital (PCH) through a combination of fresh investment and acquisition of shares from existing promoters for the aggregate sum of Rs 287 Cr. Operational since 2010, the 340-bedded Pushpanjali Crosslay hospital, which ...
-
Opportunity India Desk Sep 29, 2017 - 1 min readIn a recent business move, Essilor India Pvt Ltd has acquired 36.47 per cent stake in GKB Vision Ltd, the lens division of Goa-based ophthalmic manufacturing company GKB Ophthalmics Ltd for Rs 22.91 crore ($3.6 million), as per a stock market disclosure. Incorporated in 2000, GKB Vision manufactures ophthalmiclenses like bifocals lenses, progressive lenses, ...
-
Opportunity India Desk Sep 29, 2017 - 7 min readWith the continuously intensifying pollution, the quality of air people inhale in India is depleting day-by-day. Considerably, people across the nation spend over 90 per cent of their time indoors. Researchers believe that the indoor air is much polluted in comparison with the polluted air outside. Nevertheless, according to India Air Purifier Market Forecast & ...
-
Opportunity India Desk Sep 29, 2017 - 2 min readAccording to leading export promotion body of Pharmaceuticals, Pharmexcil, Indian pharma exports are estimated to have grown, but at a slower pace of 2.2 per cent to about $15.2 billion during the financial year ended March 2015 against $14.9 billion in the previous fiscal. As suggested by leading daily, PV Appaji, Director General, Pharmaceuticals ...
-
Opportunity India Desk Sep 29, 2017 - 1 min readPharmaceuticals major Zydus recently announced that its R&D subsidiary Etna Biotech will collaborate with US-based National Institute of Allergy and Infectious Diseases (NIAD) to develop a vaccine against visceral leishmaniasis (VL), known as Kala-Azar in India. Etna Biotech will also donate $2,40,000 for advancing research under the NIH leishmaniasis programme. Reportedly, Zydus disclosed the ...